Back to available technologies

Blood-based biomarkers for colon cancer

Using multiplex ELISA techniques we are able to assay proteins in the plasma of patients with colorectal cancer to predict whether they will respond to the biological agents most commonly used to treat that disease.

Duke File (IDF) Number

T-004936

Inventor(s)

  • Nixon, Andrew
  • Brady, Chris
  • Hatch, Ace
  • Hurwitz, Herbert
  • Jiang, Chen
  • Liu, Yingmiao
  • Owzar, Kouros
  • Sibley, Alex
  • Starr, Mark

Patents

    • Patent Number: 16/302,343
    • Title: METHODS OF PREDICTING RESPONSIVENESS OF A CANCER TO A VEGF TARGETING AGENT AND METHODS OF PROGNOSING AND TREATING CANCER
    • Country: United States of America

For more information please contact

College

School of Medicine (SOM)

Interested in this Technology?

Submit your interest below.